Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

Condition:   Thyroid Cancer Intervention:   Drug: Pembrolizumab (Keytruda) Sponsors:   Stanford University;   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials